Moderna, Merck Skin Cancer Vaccine Shows Promise in Experimental Trials
Moderna and Merck are working on an experimental skin cancer vaccine that has shown promise in early trials. The vaccine uses a different approach than traditional treatments, targeting specific genetic mutations that drive skin cancer growth.
The FDA is not involved in the development of this vaccine at this stage.